Herbalife Ltd (NYSE:HLF) Receives $17.75 Average PT from Analysts

Herbalife Ltd (NYSE:HLF) has earned a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $17.75.

Several research firms have weighed in on HLF. Mizuho raised their target price on Herbalife from $13.00 to $15.00 and gave the company a “neutral” rating in a report on Monday, March 30th. Wall Street Zen upgraded Herbalife from a “buy” rating to a “strong-buy” rating in a research note on Saturday, April 18th. Citigroup reissued a “buy” rating and set a $21.00 price objective (up from $17.00) on shares of Herbalife in a report on Thursday, February 19th. Maxim Group began coverage on Herbalife in a research note on Tuesday, January 6th. They issued a “buy” rating and a $20.00 price objective on the stock. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Herbalife in a report on Thursday, January 22nd.

Institutional Investors Weigh In On Herbalife

Large investors have recently added to or reduced their stakes in the stock. Optimize Financial Inc boosted its position in shares of Herbalife by 1.5% in the fourth quarter. Optimize Financial Inc now owns 61,426 shares of the company’s stock valued at $792,000 after acquiring an additional 880 shares during the period. Wealth Enhancement Advisory Services LLC boosted its position in shares of Herbalife by 7.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 14,176 shares of the company’s stock valued at $200,000 after acquiring an additional 933 shares during the period. The Manufacturers Life Insurance Company boosted its position in shares of Herbalife by 3.4% in the second quarter. The Manufacturers Life Insurance Company now owns 36,642 shares of the company’s stock valued at $316,000 after acquiring an additional 1,217 shares during the period. CWM LLC boosted its position in shares of Herbalife by 5.9% in the fourth quarter. CWM LLC now owns 24,229 shares of the company’s stock valued at $312,000 after acquiring an additional 1,348 shares during the period. Finally, Harbor Capital Advisors Inc. boosted its position in shares of Herbalife by 8.9% in the fourth quarter. Harbor Capital Advisors Inc. now owns 16,488 shares of the company’s stock valued at $213,000 after acquiring an additional 1,351 shares during the period.

Herbalife Stock Down 0.7%

HLF stock opened at $16.46 on Friday. The firm has a 50 day moving average of $16.21 and a two-hundred day moving average of $13.96. Herbalife has a 12 month low of $6.45 and a 12 month high of $20.40. The company has a market capitalization of $1.70 billion, a price-to-earnings ratio of 7.48, a P/E/G ratio of 0.99 and a beta of 0.95.

Herbalife (NYSE:HLF) last released its quarterly earnings results on Thursday, February 19th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.48 by ($0.03). Herbalife had a net margin of 4.53% and a negative return on equity of 35.02%. The business had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.24 billion. During the same quarter in the prior year, the business posted $0.36 EPS. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. On average, research analysts expect that Herbalife will post 2.52 EPS for the current fiscal year.

Herbalife Company Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.